chronic myeloproliferative disorder

16
CHRONIC MYELOPROLIFERATIVE DISORDER

Upload: md-specialclass

Post on 14-Dec-2014

1.198 views

Category:

Health & Medicine


1 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Chronic Myeloproliferative Disorder

CHRONIC MYELOPROLIFERATIVE

DISORDER

Page 2: Chronic Myeloproliferative Disorder

TYPES1. Chronic Myelogenous Leukemia

2. Polycythemia vera3. Essential Thrombocytosis

4. Primary Myelofibrosis

Page 3: Chronic Myeloproliferative Disorder

CHRONIC MYELOGENOUS LEUKEMIA

Page 4: Chronic Myeloproliferative Disorder

DESCRIPTIONPrimarily Adults ( 25-60 y/o )

Peak age 4th – 5th

> 90% Philadelphia Chromosome

t(9,22)(q34;q11)ABL-BCR gene translocationAffect Pluripotent stem cell

Net effect is Unregulated cell division & inhibition of apoptosis

Page 5: Chronic Myeloproliferative Disorder

PHILADELPHIA CHROMOSOME

Page 6: Chronic Myeloproliferative Disorder

Clinical Course Insidious Mild-Moderate Anemia

Microcytic to Macrocytic anemiaHypermetabolic state

Organomegaly Extramedullary Hematopoiesis Hepatosplenomegaly Mild Lymphadenopathy

Page 7: Chronic Myeloproliferative Disorder

CLINICAL COURSE Median survival is 3 years 50% enter an Accelerated PhaseIncreasing anemia, thrombocytopenia, striking basophilia

6-12 months later AML - Blastic crisis

50% Blast crisis

Page 8: Chronic Myeloproliferative Disorder

PBSMarked LeukocytosisPredominantly pmns, metamyelocytes, myelocytes

Less 10% are MyeloblastEosinophilia & BasophiliaThrombocytosis

DESCRIPTION

Page 9: Chronic Myeloproliferative Disorder

DESCRIPTION BM Hypercellular 100%

Composed mostly Maturing Granulocytic precursors

Page 10: Chronic Myeloproliferative Disorder

PBS- CML

Page 11: Chronic Myeloproliferative Disorder

Extramedullary Hematopoiesis Hepatosplenomegaly Mild Lymphadenopathy

DESCRIPTION

Page 12: Chronic Myeloproliferative Disorder

FEATURE LEUKEMOIDREACTION

CHRONIC MYELOGENOUSLEUKEMIA

1. WBC < 50 x 109/L > 50 x 109/L

2. Toxic Granulation

Positive Negative

3. Basophilia Absent Greater basophia

4. Cell Bands-prominent

Immature all stages, particularly myelocyte

5. LAP High > 100 Low < 10

6. Splenomegaly Absent Present

Philadelphia Chromosome

Absent Present

Page 13: Chronic Myeloproliferative Disorder

TREATMENT BCR-ABL kinase inhibitors

May not prevent progression to crisis

Allogenic bone marrow transplantMost effective Tx

Page 14: Chronic Myeloproliferative Disorder

POLYCYTHEMIA VERA Clonal D/O of pluripotent stem cell

Undetectable levels of eryhtropoietin

Increase in Myeloid Stem cells With progression Lead to

1. myelofibrosis2. Leukemic transformation

Page 15: Chronic Myeloproliferative Disorder

POLYCYTHEMIA VERA Late Middle age group blood Viscosity Vascular stasis Thrombotic tendency & Hemorrhagic diasthesis

Gout , Pain on affected organ Death :

30% thrombotic complications – brain, heart

5-10% Bleeding

Page 16: Chronic Myeloproliferative Disorder

DIAGNOSIS : All 3 or 2 of Major + 2 Minor MAJOR

Increased Total Erythrocyte Volume- Males > 36ml/Kg- Females > 32ml/Kg

Normal Arterial O2 saturation > 92%Splenomegaly

MINORThrombocytosis > 400 x 10 9/LLeukocytosis > 12 x 10 9 /L Increased NAP Increased Serum Vit B12 > 900 ug/L